Guangdong Provincial Hospital of Chinese Medicine has developed a number of new traditional Chinese medicines with independent intellectual property rights and market competitiveness, which are used to treat various major diseases in key specialties such as respiratory, cardiovascular, gynecological, and dermatological specialties. Furthermore, we have obtained quite a few clinical trial approvals for new drug applications and successfully transferred numerous new drug projects. Jinrong granules, created by Professor Lin Yi, a renowned TCM expert in China, have been approved for marketing and were the only new traditional Chinese medicine approved by National Medical Products Administration in 2018.
| New drug name | Clinical Trial Approval Number |
| Xiaopi Granules | 2005L01119 |
| Xiaoyan Zhiyang Gel | 2006L02764 |
| Fufang Maodongqing Granules | 2007L05130 |
| Eleng Capsules | 2008L10799 |
| Qianliebao Granules | 2009L00384 |
| Shenju Capsules | 2008L11195 |
| Zihua Wenfei Zhisou Granules | 2016L05843 |
| Peitu Qingxin Granules | 2017L04707 |
| Shaoling Tablets | 2020LP00942 |
粤公网安备 44010402000415号